stars 1 stars 2 stars 3

Nanorobotics has developed a proprietary technology to target and kill cancer cells promptly via the use of Molecular NanoMachines. These tiny machines (size 1 nm) can kill the cell mechanically by drilling and tunneling through the membrane until disrupting its nucleus. We are bringing a new modality to oncology - Mechanotherapy. Our recent animal studies have shown dramatic reduction of melanoma growth that is highly resistant to immunotherapy. And the great news - our Mechanotherapy treatment is decoupled from any cancer pathogenesis, mutational rate, or tumor microenvironment. Our programmable, light-activated, nanorobots open a revolutionary new area in nanomedicine. https://nanorobotics.tech

Nanorobotics Questions

Shlomo Nedvetzki is the CTO of Nanorobotics.

2 people are employed at Nanorobotics.

Top Nanorobotics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users